Iglehart JD - Search Results

1

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL. Kong FM, et al. Among authors: iglehart jd. Ann Surg. 1995 Aug;222(2):155-62. doi: 10.1097/00000658-199508000-00007. Ann Surg. 1995. PMID: 7543740 Free PMC article.

2

Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.

Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD, et al. Anscher MS, et al. Among authors: iglehart jd. Ann Surg. 1993 Jul;218(1):22-8. doi: 10.1097/00000658-199307000-00005. Ann Surg. 1993. PMID: 8328825 Free PMC article. Review.

3

M6P/IGF2 receptor: a candidate breast tumor suppressor gene.

Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL. Hankins GR, et al. Among authors: iglehart jd. Oncogene. 1996 May 2;12(9):2003-9. Oncogene. 1996. PMID: 8649861

4

Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases.

Coveney E, Weltz CR, Greengrass R, Iglehart JD, Leight GS, Steele SM, Lyerly HK. Coveney E, et al. Among authors: iglehart jd. Ann Surg. 1998 Apr;227(4):496-501. doi: 10.1097/00000658-199804000-00008. Ann Surg. 1998. PMID: 9563536 Free PMC article.

5

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.

Marks JR, Humphrey PA, Wu K, Berry D, Bandarenko N, Kerns BJ, Iglehart JD. Marks JR, et al. Among authors: iglehart jd. Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002. Ann Surg. 1994. PMID: 7909221 Free PMC article.

6

Relation between p53 overexpression and established prognostic factors in breast cancer.

Davidoff AM, Herndon JE 2nd, Glover NS, Kerns BJ, Pence JC, Iglehart JD, Marks JR. Davidoff AM, et al. Among authors: iglehart jd. Surgery. 1991 Aug;110(2):259-64. Surgery. 1991. PMID: 1858036

7

Overestimation of hereditary breast cancer risk.

Iglehart JD, Miron A, Rimer BK, Winer EP, Berry D, Shildkraut MJ. Iglehart JD, et al. Ann Surg. 1998 Sep;228(3):375-84. doi: 10.1097/00000658-199809000-00010. Ann Surg. 1998. PMID: 9742920 Free PMC article.

8

Testing for hereditary breast and ovarian cancer in the southeastern United States.

Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, Culler D, Calingaert B, Clark S, Kelly Marcom P, Iglehart JD. Miron A, et al. Among authors: iglehart jd. Ann Surg. 2000 May;231(5):624-34. doi: 10.1097/00000658-200005000-00002. Ann Surg. 2000. PMID: 10767783 Free PMC article. Clinical Trial.

9

The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus.

Duhaylongsod FG, Gottfried MR, Iglehart JD, Vaughn AL, Wolfe WG. Duhaylongsod FG, et al. Among authors: iglehart jd. Ann Surg. 1995 Jun;221(6):677-83; discussion 683-4. doi: 10.1097/00000658-199506000-00007. Ann Surg. 1995. PMID: 7794072 Free PMC article.

10

Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.

Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, Dewhirst M, Greenberg C. Blackwell K, et al. Among authors: iglehart jd. J Clin Oncol. 2000 Feb;18(3):600-8. doi: 10.1200/JCO.2000.18.3.600. J Clin Oncol. 2000. PMID: 10653875 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page